European Healthtech startup funding raised during Q3 2015.
In Q3 2015, 65 European Healthtech companies raised a combined €799M across 67 funding rounds, up 197.7% versus Q3 2014. Switzerland led by capital raised, and High-Tech Gr√ºnderfonds (HTGF) was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| CeQur | Series C | Aug 2015 | €89M |
| Benevolent | Growth/Late | Jul 2015 | €80M |
| Merus | Series C | Jul 2015 | €73M |
| ADC Therapeutics | Growth/Late | Aug 2015 |
3 exits · €330M disclosed.
| Biotie Therapies | Acquisition | Aug 2015 | €330M |
| €71M |
| Symphogen | Debt | Sep 2015 | €68M |
| Sanifit | Series C | Aug 2015 | €37M |
| Biom'Up | Series C | Aug 2015 | €31M |
| Therachon | Series A | Aug 2015 | €31M |
| Novadip Biosciences | Series A | Aug 2015 | €28M |
| Asceneuron | Series A | Aug 2015 | €27M |
| Replimune | Series A | Aug 2015 | €27M |
| LifeBond | Series D+ | Jul 2015 | €25M |
| Minoryx Therapeutics | Series A | Sep 2015 | €19M |
| Doctolib | Series B | Sep 2015 | €18M |
| Euroscreen | Series B | Sep 2015 | €16M |
